Latest Chrysos (ASX:C79) News

Chrysos Corporation reported a robust FY25 with 46% revenue growth and an 80% jump in EBITDA, driven by expanding adoption of its PhotonAssay technology and a landmark contract with gold giant Newmont. The company projects further growth in FY26 with revenue guidance of $80-90 million.

Chrysos Corporation reported a robust 46% revenue increase to A$66.1 million for FY25 but faced a significant net loss of A$8.2 million, reflecting rising costs and operational challenges.

Chrysos Corporation reports robust FY25 financial growth driven by global adoption of its PhotonAssay technology and secures a strategic Master Services Agreement with gold giant Newmont. The company projects further revenue and EBITDA expansion in FY26.

Chrysos Corporation reported a strong FY25 with 46% revenue growth and key contracts signed with industry leaders, setting an optimistic tone for FY26.

Chrysos Corporation has secured a landmark Master Services Agreement with Newmont Corporation, marking its first PhotonAssay unit deployment at the Ahafo mine in Ghana. This deal signals growing adoption of Chrysos’ cutting-edge gold analysis technology among top-tier miners.

Chrysos Corporation reported a 25% year-on-year revenue increase in Q3 FY25, driven by strong growth in sample volumes and expanded deployment of its PhotonAssay technology across key mining regions.

Chrysos Corporation reports a robust Q2 FY25 with a 12% quarter-on-quarter and 53% year-on-year revenue increase, driven by expanding international sales and rising sample volumes. The company secured two new contracts, boosting its PhotonAssay™ footprint and maintaining strong financial health.